Zhechuan Mei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhechuan Mei has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Biao Deng
Department of General Surgery, Shanghai First People’s Hospital, Shanghai Jiao Tong University, Shanghai, China
2 shared publicationsJiaqing Fang
Department of Gastroenterology, Tianyou Hospital, TongJi University, Shanghai, China
2 shared publicationsJinfang Li
Department of Neurology, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
2 shared publicationsLei Qu
Department of General Surgery, Shanghai First People’s Hospital, Shanghai Jiao Tong University, Shanghai, China
2 shared publicationsShouwen Yang
Department of General Surgery, Shanghai First People’s Hospital, Shanghai Jiao Tong University, Shanghai, China
2 shared publications- Xing Sun
Department of General Surgery, Shanghai First People’s Hospital, Shanghai Jiao Tong University, Shanghai, China
2 shared publications
Latest Publications
- RetractionOpen Access
- 24 July 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1
Retraction Note: MiRNA-211 suppresses cell proliferation, migration and invasion by targeting SPARC in human hepatocellular carcinoma
- 24 July 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1
RetractionOpen AccessRetraction Note: MiRNA-211 suppresses cell proliferation, migration and invasion by targeting SPARC in human hepatocellular carcinoma
- RetractedOpen Access
- 27 May 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 26679
RETRACTED ARTICLE: MiRNA-211 suppresses cell proliferation, migration and invasion by targeting SPARC in human hepatocellular carcinoma
Previous studies have shown that the expression of miR-211 was downregulated in hepatocellular carcinoma (HCC). However, the molecular function and mechanism of miR-211 in HCC growth and invasion are largely unclear. We found that miR-211 is downregulated in HCC tissues and cell lines, respectively. Further results showed that low miR-211 associated with TNM stage, vein invasion status and poor prognosis. Ectopic expression of miR-211 effectively suppressed HCC cell proliferation, migration and invasion bothin vitroandin vivo. We identified SPARC as a bona fide target of miR-211 and overexpression of miR-211 decreased the mRNA and protein expression of SPARC. Finally, we confirmed that the overexpression of SPARC in miR-211-expressing HCC cells can partially restore the inhibitory effect of miR-211. Taken together, our results demonstrated that loss of miR-211 expression and thus uncontrolled SPARC overexpression might drive progression of HCC, which may provide a novel therapeutic strategy for the treatment of HCC.
- 27 May 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 26679
RetractedOpen AccessRETRACTED ARTICLE: MiRNA-211 suppresses cell proliferation, migration and invasion by targeting SPARC in human hepatocellular carcinoma
Previous studies have shown that the expression of miR-211 was downregulated in hepatocellular carcinoma (HCC). However, the molecular function and mechanism of miR-211 in HCC growth and invasion are largely unclear. We found that miR-211 is downregulated in HCC tissues and cell lines, respectively. Further results showed that low miR-211 associated with TNM stage, vein invasion status and poor prognosis. Ectopic expression of miR-211 effectively suppressed HCC cell proliferation, migration and invasion bothin vitroandin vivo. We identified SPARC as a bona fide target of miR-211 and overexpression of miR-211 decreased the mRNA and protein expression of SPARC. Finally, we confirmed that the overexpression of SPARC in miR-211-expressing HCC cells can partially restore the inhibitory effect of miR-211. Taken together, our results demonstrated that loss of miR-211 expression and thus uncontrolled SPARC overexpression might drive progression of HCC, which may provide a novel therapeutic strategy for the treatment of HCC.